West Pharmaceutical Services, Inc. Common Stock (WST) stock analysis
WST · West Pharmaceutical Services, Inc. Common Stock
Latest recorded price: USD 417.80
Model-estimated fair value: USD 109.14. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Instruments & Supplies
At $417.80, WST trades 282.8% above the model's base-case value of $109.14. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $89.46 in the conservative case and $131.26 in the optimistic case, with a valuation confidence score of 85/100. About 71% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 2.1%, free cash flow margin 15.3%, ROIC 15.9%. The model does not flag any risk signals for this company.